IDH2 and central nervous system cancer: Although from a small sample, these data suggest that patients with Ollier disease harboring the IDH1 R132H mutation in enchondroma are at major risk of developing gliomas, compared to enchondromatosis patients with the IDH R132C mutation in enchondroma.